MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-08-0003367
Meddoxx Pharmaceuticals Private Limited
Meddoxx Pharmaceuticals Private Limited - pharma in Kozhikode, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.03 Cr
▲ 14% YoY
Net profit · FY 2025
₹73.9 Lakh
Net margin 5.7%
EBITDA · FY 2025
₹1.32 Cr
EBITDA margin 10.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
58
Provident fund records
About Meddoxx Pharmaceuticals Private Limited
Data last updated:
Meddoxx Pharmaceuticals Private Limited is a private limited company based in Kozhikode, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2014PTC036243. Its GSTIN is 32AAJCM2091H1ZL (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajeev Kolayadath (Managing Director) and Gopi Krishna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 69/3241 A K.C Arcade Nellikavu Road, Karaparamba Kozhikode, Kerala, India – 673010.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.03 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹73.9 Lakh (net margin 5.7%) and EBITDA of ₹1.32 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 17% over five years.
The company has about 58 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3 Cr on record.
Meddoxx Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-08-0003367). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232KL2014PTC036243
Registration Number 036243
Incorporation Date 22 February 2014
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-08-0003367
Recognitions & Rankings of Meddoxx Pharmaceuticals
Contact details
Meddoxx Pharmaceuticals Private Limited's registered office is in Kozhikode, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address69/3241 A K.C Arcade Nellikavu Road, Karaparamba Kozhikode, Kerala, India – 673010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Meddoxx Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Meddoxx Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meddoxx Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Meddoxx Pharmaceuticals Private Limited, buy the company report.
Financials of Meddoxx Pharmaceuticals Private Limited
FY 2025 filings availableMeddoxx Pharmaceuticals Private Limited reported revenue of ₹13.03 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹13.03 Cr ▲ 14%
Net profit · FY 2025
₹73.9 Lakh margin 5.7%
EBITDA · FY 2025
₹1.32 Cr margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 18%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 7%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 14% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meddoxx Pharmaceuticals Private Limited, buy the company report.
Board of directors of Meddoxx Pharmaceuticals Private Limited
Meddoxx Pharmaceuticals has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kolayadath | Managing Director | 22 Feb 2014 | 12 Years 8 Months | Current |
| Gopi Krishna | Director | 22 Feb 2014 | 12 Years 8 Months | Current |
| Manoj Madhavan Nair | Director | 22 Feb 2014 | 12 Years 8 Months | Current |
| Manojkumar Madappally Chakkiath | Director | 05 Jun 2017 | 9 Years 4 Months | Current |
| Dhinkar Krishnan | Director | 22 Feb 2014 | 12 Years 8 Months | Current |
| Vinesh Nadu Kandy | Director | 22 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
Meddoxx Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SLB Pharma Private Limited | ₹13.1 Cr (FY 2025) | 78.0% | Telangana, India | |||
| Meddoxx Pharmaceuticals Private Limitedthis company | ₹13.03 Cr (FY 2025) | ₹73.9 Lakh | 5.7% | 14.0% | 58 | Kozhikode, Kerala, India |
| Aster Medicines Private Limited | ₹13 Cr (FY 2025) | 20.0% | Patna, Bihar, India | |||
| Middle Mist Pharmaceuticals Private Limited | ₹12.96 Cr (FY 2025) | -6.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Meddoxx Pharmaceuticals Private Limited, buy the company report.
Auditor
Meddoxx Pharmaceuticals Private Limited is audited by Suresh Pai for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suresh Pai | FY 2023 | 209708 |
Shareholding
The shareholding of Meddoxx Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Meddoxx Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Dec 2025 | 101213727 | Others | ₹50 Lakh | Open | |
| 19 Dec 2025 | 101213738 | Others | ₹50 Lakh | Open | |
| 19 Dec 2025 | 101213858 | Others | ₹50 Lakh | Open | |
| 19 Dec 2025 | 101213866 | Others | ₹50 Lakh | Open | |
| 19 Dec 2025 | 101213876 | Others | ₹50 Lakh | Open |
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Meddoxx Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meddoxx Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Meddoxx Pharmaceuticals Private Limited has a workforce of 58 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
58
Active EPFO establishments
1
Employee growth
11.54%
GST
Meddoxx Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAJCM2091H1ZL | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Meddoxx Pharmaceuticals Private Limited, buy the company report.
Recent activity
Meddoxx Pharmaceuticals Private Limited has 8 board changes on record since 2014: 7 appointments and 1 cessation. The latest: Manojkumar Madappally Chakkiath was appointed as Director on 05 Jun 2017.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101213727 was registered on 19 Dec 2025.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101213738 was registered on 19 Dec 2025.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101213858 was registered on 19 Dec 2025.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101213866 was registered on 19 Dec 2025.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101213876 was registered on 19 Dec 2025.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101213892 was registered on 19 Dec 2025.
AGM
Meddoxx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Meddoxx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Appointed
Manojkumar Madappally Chakkiath was appointed as Director.
Ceased
Priya Koodakkayil ceased to be Director.
Appointed
Dhinkar Krishnan was appointed as Director.
Appointed
Gopi Krishna was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
Meddoxx Pharmaceuticals is an active private limited company based in Kozhikode, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 2014 (12+ years old) and is registered under CIN U24232KL2014PTC036243.
Meddoxx Pharmaceuticals has 6 current directors:
- Rajeev Kolayadath - Managing Director
- Gopi Krishna - Director
- Manoj Madhavan Nair - Director
- Manojkumar Madappally Chakkiath - Director
- Dhinkar Krishnan - Director
- Vinesh Nadu Kandy - Director
The latest financial statements of Meddoxx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Meddoxx Pharmaceuticals is 32AAJCM2091H1ZL, registered in Kerala.
The CIN (Corporate Identification Number) of Meddoxx Pharmaceuticals is U24232KL2014PTC036243. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meddoxx Pharmaceuticals was incorporated on 22 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Meddoxx Pharmaceuticals by revenue are SLB Pharma Private Limited, Aster Medicines Private Limited, Middle Mist Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manojkumar Madappally Chakkiath was appointed as Director on 05 Jun 2017. Priya Koodakkayil ceased to be Director on 05 Jun 2017. Dhinkar Krishnan was appointed as Director on 22 Feb 2014. Meddoxx Pharmaceuticals has 8 board changes on record in total.
Yes, Meddoxx Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-KL-08-0003367).
The registered office of Meddoxx Pharmaceuticals is at 693241 A K.C Arcade Nellikavu Road, Karaparamba Kozhikode, Kerala, India – 673010.
Meddoxx Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages